Ex Vivo Expansion of Cord Blood-Derived Endothelial Cells Using a Novel Xeno-Free Culture Media
Author(s) -
Ayokunle A. Ogunye,
Ian McNiece,
S. Daniliuc,
Mira Genser-Nir,
Y. Miropolski,
D. Fiorentini,
Joshua Kellner
Publication year - 2019
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.2144/fsoa-2018-0103
Subject(s) - cd31 , matrigel , progenitor cell , ex vivo , cord blood , cd34 , flow cytometry , in vivo , endothelial progenitor cell , bone marrow , microbiology and biotechnology , immunology , chemistry , biology , stem cell , immunohistochemistry
Aim: Endothelial cells (ECs), isolated from peripheral blood (PB), bone marrow (BM) and cord blood (CB), are limited in numbers and expansion has had limited success. We used a novel serum-free medium (EndoGo) to evaluate effects on ex vivo expansion of CB-derived ECs. Materials & methods: Flow cytometry and matrigel were used to determine expansion of ECs and for determination of the EC progenitor cell. Results: EndoGo™-containing cultures demonstrated superior expansion and stimulated proliferation of two distinct subpopulations, CD34 + CD31 + and CD34 - CD31 + , which exhibited different morphology, phenotype and function. EndoGo also expanded the CB endothelial progenitor cells from freshly isolated CB. Conclusion: These findings demonstrate the potential of EndoGo to expand CB ECs, which could generate increased numbers of ECs for therapeutic applications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom